N 6 -methyladenosine (m 6 A) is the most prevalent internal modification of mammalian messenger RNAs (mRNAs) and long non-coding RNAs. The biological functions of this reversible RNA modification can be interpreted by cytoplasmic and nuclear 'm 6 A reader' proteins to fine-tune gene expression, such as mRNA degradation and translation initiation. Here we profiled transcriptome-wide m 6 A sites in adult mouse cerebral cortex, underscoring that m 6 A is a widespread epitranscriptomic modification in brain. Interestingly, the mRNA targets of fragile X mental retardation protein (FMRP), a selective RNA-binding protein, are enriched for m 6 A marks. Loss of functional FMRP leads to Fragile X syndrome (FXS), the most common inherited form of intellectual disability. Transcriptome-wide gene expression profiling identified 2035 genes differentially expressed in the absence of FMRP in cortex, and 92.5% of 174 downregulated FMRP targets are marked by m 6 A. Biochemical analyses indicate that FMRP binds to the m 6 A sites of its mRNA targets and interacts with m 6 A reader YTHDF2 in an RNA-independent manner. FMRP maintains the stability of its mRNA targets while YTHDF2 promotes the degradation of these mRNAs. These data together suggest that FMRP regulates the stability of its m 6 A-marked mRNA targets through YTHDF2, which could potentially contribute to the molecular pathogenesis of FXS.
Introduction
Epigenetic regulation has been shown to play pivotal roles in the development and functions of central nervous system. N 6 -methyladenosine (m 6 A) is the most prevalent internal modif ication of mammalian messenger RNAs (mRNAs) and long non-coding RNAs (lncRNAs) (1) . A multi-component methyltransferase complex containing several subunits (METTL3, METTL14, WTAP, KIAA1429/VIRMA, RBM15 and RBM15B) installs m 6 A (2-6). Two demethylases of the AlkB dioxygenase family, FTO and ALKBH5, remove m 6 A (7, 8) . The biological functions of this dynamic RNA modification can be interpreted by many cytoplasmic and nuclear proteins (known as 'm 6 A readers') to fine-tune multiple steps in RNA life cycle, such as nuclear pre-mRNA splicing (YTHDC1 and HNRNPA2/B1), nuclear export of mRNA (YTHDC1), microRNA generation (HNRNPA2/B1), translation initiation (YTHDF1, YTHDF3, YTHDC2 and eIF3) and mRNA degradation (YTHDF2 and YTHDC2) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) . In addition, m 6 A can change the accessibility of its surrounding sequence by altering the local structures in mRNAs and lncRNAs, thus modulate the interaction between RNA and RNA binding proteins (a mechanism known as 'm 6 A-switch') (20, 21) . m 6 A is particularly abundant in mammalian brain and the methylome is conserved in mammals (22, 23) . We and others have revealed prominent functions of m 6 A methylase and demethylase in the proliferation and differentiation of adult neural stem cells, cortical neurogenesis, hippocampal learning and memory, midbrain dopaminergic signaling and circadian clock control (24) (25) (26) (27) (28) . Fragile X syndrome (FXS, OMIM#300624) is the most common inherited form of intellectual disability and a leading genetic cause of autism spectrum disorders (ASD) (29) (30) (31) . FXS is caused by loss of functional fragile X mental retardation protein (FMRP) (32) . FMRP, encoded by FMR1 gene, is a selective RNA-binding protein associated with translating polyribosomes (polysome) (33) (34) (35) . It represses and regulates translation of a set of synaptic plasticity-related transcripts. Coinciding with m 6 A, FMRP is also particularly abundant in brain with high expression in neurons. Intriguingly, the consensus sequence for m 6 A methylation, RGACH (R = A/G; H = A or C/U) largely overlaps with FMRPbound YGGA (Y = C/U) and GAC motifs and is found in 57% of FMRP consensus binding sites (22, 23, (36) (37) (38) . Furthermore, FMRP has recently been shown to bind an m 6 A-containing RNA probe (GGACU) 4 (39) .
In this study, we determined the transcriptome-wide m 6 A sites in adult mouse cerebral cortex using anti-m 6 A RNA immunoprecipitation (RIP) followed by high-throughput sequencing (m 6 A-seq). We found that the mRNA targets of FMRP are significantly enriched for m 6 A marks, and the loss of FMRP alters both transcriptome and epitranscriptome in cortex. Surprisingly, among FMRP targets, at least 92% of Fmr1 KOdownregulated mRNAs were marked by m 6 A [with an odds ratio (OR) near 7] , suggesting that FMRP could have interplay with m 6 A-mediated regulation of mRNA stability. Our biochemical analyses indicated that FMRP could bind to m 6 A sites in its targets and interact with YTHDF2, an 'm 6 A reader', in an RNA-independent manner. Functionally, we showed that FMRP maintains the stability of its mRNA targets while YTHDF2 promotes the degradation of these transcripts. Together, our works demonstrate that FMRP regulates the stability of its mRNA targets marked by m 6 A, most likely through YTHDF2. This mechanism represents an additional layer of gene regulation mediated by FMRP, which could potentially contribute to the molecular pathogenesis of FXS.
Results m 6 A RNA methylation is a widespread mRNA modification in mouse cerebral cortex
To determine the landscape of m 6 A in mammalian brain, we profiled the transcriptome-wide m 6 A sites in the cerebral cortex of 6 week old male mice using m 6 A-seq (Supplementary Material, Fig. S1A ) (28, 40) . Poly(A)(+) RNA isolated from cortex tissue of six mice were pooled for each assay. m 6 A-seq identified about 22 000 genome-based peaks (false discovery rate, FDR, < 0.001) shared between two biological replicates as high-confidence m 6 A peaks (or 'HC peaks') and 7587 mRNAs and ncRNAs as Table S1 ), suggesting that m 6 A is a widespread regulatory mechanism for transcripts in adult cortex. In total 93% of HC peaks occur within genic regions (Fig. 1A) , which are abundant in exons (75%), and highly enriched for 3' untranslated region (UTR) (38-fold), coding sequences (CDS) (36-fold) and 5' UTR (25-fold) . In addition, a deduced consensus motif, RGACH (R = A/G; H = A or C/U), was greatly enriched in the HC peaks (Fig. 1B) . Table  S1 ). However, 2858 peaks were found only in WT cortex but not in any replicate of KO cortex (defined as WT-specific peaks), while 2769 peaks were found only in KO but not in any replicate of WT (defined as KO-specific peaks) ( Fig Table S1 ). Like most RIPbased experiments, m 6 A signal detection relies on transcripts expressed at sufficient level. We compared the expression levels of 2016 transcripts marked by WT-specific peaks in WT and KO cortex and found that only < 14% of these transcripts were significantly downregulated in KO cortex (Supplementary  Material, Fig. S2H, and Tables S1 and S2) . Similarly, among 1143 transcripts containing KO-specific peaks, < 14% were significantly upregulated by Fmr1 KO in cortex (Supplementary Material, Fig. S2H and Tables S1 and S2 ). These findings indicate that the majority of WT-and KO-specific peaks identified by our m 6 A-seq experiments were not due to altered transcript abundance. In addition, we noticed that the expression levels of transcripts marked by WT-specific peaks and by common peaks were overall very close to each other in both WT and KO cortex, but the transcripts marked by KO-specific peaks in general were expressed at lower level than the transcripts marked by common peaks in both WT and KO cortex (Fig. 2D) . Finally, there were 2016 and 1143 genes whose transcripts were marked by WT-and KO-specific m 6 A peaks, respectively ( Fig. 2E and F HC peaks or HC genotype-specific m 6 A peaks in WT or KO cortex. Lower/middle/upper position in bar plots indicate 25/50/75% quantile, respectively. *, P-value < 0.05; ****, P-value < 0.0001; n.s., not significant, two-tailed Mann-Whitney U-test. (E and F) GO analyses of genes whose transcripts contained at least one WT-specific (E) or KO-specific (F) m 6 A peak in 6 week old cortex.
(taking exon-exon junctions and reads' variances among replicates into consideration) and to detect differential methylation (DM) among these m 6 A sites (Fmr1 KO versus WT). In total the transcripts of 5963 genes were found to harbor at least one exome-based m 6 A peak in both WT and KO cortex (Supplementary Material, Fig. S3C and Table S2 ). GO analyses showed that 952 Fmr1 KO-upregulated genes were mainly enriched for GO terms related to translation and energy (ATP) production, while 1083 Fmr1 KO-downregulated genes were enriched for biological processes like transcription, intracellular signaling transduction, epigenetic modification and Fig. S4C and D). Furthermore, even in WT cortex, these downregulated mRNAs on average were expressed at lower level than those not downregulated ( Fig. 3E ). Also, in either WT or KO cortex, the 161 downregulated mRNAs in general harbored more exome-based m 6 A peaks than the 429 mRNAs not downregulated (Fig. 3F ), but tag enrichment (IP/non-IP ratio within m 6 A peaks) between these two groups showed no sig- Fig. S4E ). Lastly, we compared the distribution patterns of exome-based m 6 A peaks across the length of these two groups of mRNAs. Metagene plot revealed that m 6 A peaks from 161 Fmr1 KO-downregulated FMRP targets were more enriched in the CDS than m 6 A peaks from 429 FMRP targets that were not downregulated by Fmr1 KO. But the distribution patterns of FMRP-CLIP tags (36) in these two groups of mRNAs were similar (predominantly in the CDS) ( Fig. 3G ). In summary, we discovered that the loss of FMRP in cortex led to significant downregulation of a subset of m 6 Amarked FMRP target mRNAs sharing characteristics like having long CDS marked by m 6 A peaks and being moderately expressed.
These findings suggested a mechanistic link between the m 6 A modification on this subset of FMRP targets and the reduced levels of these mRNAs when FMRP was missing.
FMRP binds to m 6 A sites and is associated with an m 6 A reader, YTHDF2
The role for m 6 A in regulating mRNA stability has been well established. YTHDF2, a cytoplasmic m 6 A reader protein of the YT521-B homology (YTH) domain family, expedites the decay of m 6 A-marked transcripts by recruiting the CCR4-NOT deadenylase complex (44) and by targeting its cognate mRNAs for degradation in processing bodies (18) . Notably, the more m 6 A/YTHDF2-binding sites one transcript contains, the larger destabilizing effect YTHDF2 will bring to that transcript (18) . Since the consensus binding motif of YTHDF2 (18) (Fig. 4B) . We further examined whether FMRP could directly interact with YTHDF2. In a co-immunoprecipitation (co-IP) assay, FLAGtagged YTHDF2 was transfected into mouse Neuro 2a (N2A) cell line. Anti-FLAG IP followed by anti-FMRP blotting demonstrated that endogenous FMRP interacted with YTHDF2 (Fig. 4C) . The interaction between these two RNA-binding proteins was not RNA-dependent since the RNase treatment did not abolish their association (Fig. 4C) . Furthermore, EGFP-FLAG-tagged FMRP and FLAG-tagged YTHDF2 were co-transfected into human HEK293T cells for reciprocal IP. Anti-GFP IP followed by anti-FLAG blotting confirmed that FMRP interacts with YTHDF2 in an RNA-independent manner (Fig. 4D) Fig. S7 ).
FMRP is known to repress the translation of a set of synaptic plasticity-related mRNAs by causing translating ribosomes to stall and accumulate on the mRNA (36) . This repression can be relieved by dephosphorylation and ubiquitination of FMRP, presumably in response to synaptic activation, resulting in rapid protein production with precise timing (50, 51) . Recently, a competition between FMRP and YTHDF1 for binding to m 6 A sites has been speculated (39) . If confirmed, this competition will suggest an antagonism between FMRP and m 6 A pathway in the control of translational efficiency of mRNAs. In addition, a role for FMRP in the control of mRNA stability has been proposed. For example, FMRP stabilizes one of its targets, Dlg4 (PSD-95) mRNA, in hippocampus but not in cortex (52) . FMRP has also been shown to destabilize Nxf1 mRNA in N2A cells (53) . However, neither of these two mRNAs contain exome-based m 6 A peak in cortex (Supplementary Material, Tables S2 ). This finding supports that FMRP-mediated regulation on mRNA stability may be relevant to the autistic features in FXS. Since a stringent set of 842 FMRP target transcripts and stringent m 6 A peak calling algorithms were used in our study, the true number of mRNAs whose decay is modulated by both FMRP and m 6 A pathway may be underestimated.
In summary, we show that m 6 A is a widespread epitranscriptomic modification in mammalian cortex, and FMRP modulates the stability of its mRNA targets in concert with m 6 A pathway. Also, we revealed dysregulated transcriptome and epitranscriptome in the absence of FMRP, providing a resource for studying molecular pathogenesis of FXS. The work presented here represents the first link between FMRP and m 6 Aregulated neural mRNA stability, which could contribute to the pathogenesis of FXS.
Materials and Methods

Animals
Control WT mice (C57BL/6J, Jackson Laboratory, Bar Harbor, ME, stock # 000664) and Fmr1 KO mice (generated on the same background, C57BL/6J Fmr1 tm1Cgr , available from Jackson Laboratory, stock # 003025) were housed, maintained and euthanized according to the Emory University Institutional Animal Care and Use Committee guidelines. Fmr1 KO males and their WT male littermates were obtained by crossing WT males with Fmr1 tm1Cgr heterozygous females. Genotyping was determined by standard PCR using a mutant reverse primer (5 -TTCGACCACCAAGCGAAACATC-3 ) or a WT reverse primer (5 -TCCAGCTTGATCTTATGGAAAG-3 ), with a common forward primer (5 -GTGATAGAATATGCAGCATGTG-3 ). Hemizygous mutant males and WT males generate ∼750 bp and ∼120 bp PCR products, respectively.
m 6 A-seq
Six week old male mice were euthanized using CO 2 . Total cellular RNA was isolated from fresh mouse cortex using TRIzol Reagent (Thermo Fisher, Waltham, MA) and Phase Lock Gel, Heavy (QuantaBio, Beverly, MA) per manufacturers' protocols. For each biological replicate, total RNA samples isolated from the cortex of six 6 week old male mice were pooled. mRNA isolation and clean up, m 6 A-RIP, RNA-seq library preparation and next-generation sequencing were performed as previously described (28) .
Mammalian cell culture and siRNA transfection
N2A mouse neuroblastoma cells (ATCC, Manassas, VA, CCL-131) were grown in Minimum Essential Medium (Corning, Corning, NY, 10-009-CV), supplemented with 10% (vol/vol) fetal bovine serum (FBS) (Atlanta Biologicals, Flowery Branch, GA) and 100 units/mL penicillin plus 100 μg/mL streptomycin (Thermo Fisher). 293T human embryonic kidney epithelial cells expressing SV40 T antigen (ATCC, CRL-3216) were grown in Dulbecco's Modified Eagle Medium (DMEM) (Thermo Fisher, 11995065), supplemented with 10% FBS, 2 mm L-glutamine (Thermo Fisher) and 100 units/mL penicillin plus 100 μg/mL streptomycin. The genotypes of transformed cell lines were verified by ATCC, and only cells with low passage number (< 20) were used. All cells were maintained in a humidified incubator at 37
• C in an atmosphere of 5% CO 2 . Dharmacon ON-TARGETplus SMARTpool mouse Fmr1 siRNA (L-045448-00), mouse Ythdf1 siRNA (L-050937-01) and mouse Ythdf2 siRNA (L-058271-01) were used to downregulate Fmr1, Ythdf1 and Ythdf2 in N2A cells, respectively. Qiagen negative control siRNA (1027310) was used as the scrambled control. For RNA interference, 25 nM siRNA oligos were transfected into N2A cells (for example, 0.5 million cells plated about 16 h ago in 2 mL of growth medium) using Lipofectamine RNAiMAX (Thermo Fisher) per manufacturer's protocol. One day later, transfected cells were split (1:3) with fresh growth medium.
Western blotting
Six week old male mouse cortex was homogenized and lysed in RIPA buffer ( Densitometric quantification of western blotting images was performed using ImageJ/Fiji (56) . No pixel used for quantification was overexposed.
Quantitative RT-PCR
Total cellular RNA was purified from N2A cells (72 h after transfection) using TRIzol Reagent and Direct-zol RNA MiniPrep Kit (Zymo Research, Irvine, CA) per manufacturers' protocols. RNA concentration was determined by a NanoDrop 2000 Spectrophotometer (Thermo Fisher), and 1 μg of total RNA was used to synthesize first-strand cDNA. SuperScript III First-Strand Synthesis System for RT-PCR (Thermo Fisher) and random hexamer priming were used. SYBR Green qPCR was performed as previously described (57) . TaqMan gene expression assay was used for Neat1: 1 μL of sequence-specific TaqMan gene expression primers (20×; Thermo Fisher, Mm01720914_g1), 1 μL of reverse transcription product, 10 μL of TaqMan Universal PCR Master Mix II No UNG (2×; Thermo Fisher) and 8 μL of nuclease-free water. All qPCR reactions were performed in triplicates, and the results were analyzed using the C T method. The internal control for siRNA-transfected N2A cells was Rpl15. All SYBR Green qPCR primers were designed to span exon-exon junctions (see Supplementary Material, Table S4 for their sequences).
RNA decay
N2A cells transfected with siRNA(s) were re-plated into 12-well plates at 24 h after transfection and were cultured to ∼80% confluence at 72 h after transfection. 5 μm of actinomycin D (Sigma-Aldrich, A9415) was added to inhibit transcription. At 15 min, 2 or 4 h after actinomycin D treatment, cells were washed once with PBS and then lysed in 0.35 mL of Buffer RLT (Qiagen, Hilden, Germany) supplemented with 1% β-mercaptoethanol. Cell lysate was passed through a QIAshredder spin column (Qiagen), and 10 μL of homogenized cell lysate was taken for the quantitation of DNA content using Quant-iT PicoGreen dsDNA Kit (Thermo Fisher) and a Synergy H4 Multi-Detection Microplate Reader (BioTek) per manufacturer's instructions. Before RNA purification, 0.5 ng of luciferase control RNA (Promega, Madison, WI) per 1 μg of DNA content was added to each sample. Total cellular RNA was extracted using RNeasy Micro Kit (Qiagen), and RT-qPCR was performed. For each transcript, C T was calculated by subtracting the average of C T numbers of the spike-in luciferase control RNA from the C T number of the transcript in each sample. And then C T for each sample was calculated by subtracting the average of C T for the total RNA isolated at 15 min after actinomycin D treatment. The log 2 relative levels of the transcript at the three time points (15 min, 2 and 4 h) were plotted against time, and a linear regression was used to determine the slope, which is the decay rate (k).
co-IP
Human full-length FMR1 tagged with EGFP and FLAG at the N terminus in the FUGW plasmid (58) 
RIP
RIP procedure was adapted from a previous report (59) . Two days after plating 1.7 million cells per 10 cm dish, N2A cells in two 10 cm dishes were washed twice with ice-cold PBS, collected by cell scraper into ice-cold PBS and pelleted by centrifuge at 500 g, 4
• C for 5 min. The fresh cell pellet was re-suspended with 2 mL of RIP lysis buffer (300 mm NaCl, 50 mm Tris•HCl pH 7.4, 30 mm EDTA and 0.5% Triton X-100) supplemented with protease inhibitor cocktail and 200 U/ml RNaseOUT Recombinant Ribonuclease Inhibitor (Thermo Fisher) and incubated on ice for 10 min. The cell lysate was passed through a small needle (e.g. 26G) several times and centrifuged at 20 000 g, 4
• C for 15 min. 80 μL of supernatant was saved as input (10%) for RNA extraction, and another 80 μL of supernatant was set aside for protein analysis. 50 μl of Dynabeads Protein G (Thermo Fisher) was washed twice with 0.7 mL of RIP lysis buffer and resuspended with 150 μL of RIP lysis buffer. 10 μg of rabbit anti-FMRP polyclonal antibody (abcam, ab17722) or 10 μg of normal rabbit IgG (as a control; Cell Signaling Technology) was added to the re-suspended magnetic beads, and the mixture was rotated continuously at room temperature for 30 min. After incubation, beads-antibody complex was washed four times with 0.7 mL of RIP lysis buffer, mixed with 0.8 mL of cleared cell lysate and then rotated continuously at 4 • C for 3 h. The tubes were centrifuged briefly and placed on a magnetic separator. 80 μL of supernatant was set aside as flow-through (10%) for protein analysis; the beads were collected, washed five times with 0.7 mL of RIP lysis buffer at 4
• C and re-suspended with 0.5 mL of RIP lysis buffer. 
Bioinformatics analyses
High-throughput sequencing data in this study are summarized in (Supplementary Material, Table S5 ). Genome-based m 6 A peaks were identified and annotated as previously described (28) , except updated versions of Bowtie (v2.2.4) (60) and Homer (v4.7.2) (61) software were used. When the distance between two peak centers is within 100 bp (about the average size of RNA fragments used in m 6 A-IP), the two peaks are considered as overlapping (Supplementary Material, Fig. S1C ). Integrative Genomics Viewer (IGV) (62, 63) was used for creating tiled data files (.tdf) from BAM files (.bam). Genome-wide coverage data were scaled by 1 000 000/total read count and visualized in IGV. DREME (v4.12.0) (64) was used to discover enriched motifs with top 1000 scored HC peaks. Shuffled input sequences were used as control sequences, and only given strand was searched. CentriMo (v4.12.0) (65) was used to search centrally enriched motifs in all HC peaks. Only given strand was searched, and weighted moving average with a 30 nt window was used to smooth plots. Exome-based m 6 A peaks (fold enrichment ≥ 2) and DM (FDR ≤ 0.05) in m 6 A-seq data of WT and Fmr1 KO cortex were identified and annotated by R using MeTPeak (v1.1) (42) and MeTDiff (v1.1.0) (43) packages from RNA-seq reads aligned to mouse genome (build mm9) by Tophat v2.0.13 (66) . DM sites are defined as the ones with FDR ≤ 0.05 and fold enrichment of the peaks on the hypermethylated side being consistently larger than 2. The FPKM values for gene expression were calculated by Cufflinks (v2.2.1) (67) using UCSC annotation mm9. Stably expressed genes were defined as FPKM ≥ 0.2. Differentially expressed genes were identified by Cuffdiff (v2.2.1) (68) using UCSC mm9 and defined as q-value ≤ 0.05. R was used for statistical processing and visualizing data. MetaPlotR (69), a Perl/R pipeline was used to create the metagene plot. BEDTools closestBED (70) was used to calculate the distance between an exome-based m 6 A peak and the nearest FMRP-or ELAVL1-CLIP tag. GSM1098057 in the dataset GSE45148 was chosen for FMRP-CLIP, because it contains significantly more tags obtained by Illumina sequencing (36) . GSM1098059 is from the matched ELAVL1-CLIP experiment (36 
Statistical analyses
Investigators were not blinded to in vitro experiments. The differences between two groups were determined with at least three replicates, and equal variances were assumed. Details of statistical analyses are included in figure legends. An alpha level of 0.05 was used for significance. Two-tailed t-test, MannWhitney U-test and Wilcoxon matched-pairs signed rank test, and linear regression were performed in Prism 7 (GraphPad Software). Fisher's exact test, Chi-square test and Pearson's r test were performed in R. P-values are indicated in figures and figure legends. When calculating statistical significance of overlapping genes sets, all genes stably expressed in our RNA-seq dataset were used as the total set of genes, and the numbers are indicated in figure legend.
Data and code availability
The m 6 A-seq data reported in this paper have been submitted to Gene Expression Omnibus (http://www.ncbi.nlm.nih.gov/geo/) with accession number GSE107434. Other data including m 6 A peak calling and annotation, FMRP targets, autism spectrum disorder-associated genes, differential gene expression analyses and overlap analyses are shown in (Supplementary Material,  Tables S1-3 ). All other relevant data are available from the corresponding author. Command used to run Homer findPeaks is shown in (Supplementary Material, Table S1 ). Commands used to run Bowtie, IGV tools, Tophat, MeTPeak, MeTDiff, Cufflinks, Cuffdiff or MetaPlotR are included in the manuals of corresponding software, which are available on the internet. R code used to perform bioinformatics analyses is available upon request.
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